<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 30 Jul 2026 06:10:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+30/26837995.html</link>
   <description>si-local-file:///var/storage/secattach/20260730/26837995.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+30/26837995.html</guid>
   <pubDate>Thu, 30 Jul 2026 06:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+30/26837995.html</link>
   <description>si-local-file:///var/storage/secattach/20260730/26837995.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+30/26837995.html</guid>
   <pubDate>Thu, 30 Jul 2026 06:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+30/26837995.html</link>
   <description>si-local-file:///var/storage/secattach/20260730/26837995.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+30/26837995.html</guid>
   <pubDate>Thu, 30 Jul 2026 06:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 28</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+28/26821738.html</link>
   <description>si-local-file:///var/storage/secattach/20260728/26821738.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+28/26821738.html</guid>
   <pubDate>Tue, 28 Jul 2026 06:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 28</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+28/26821738.html</link>
   <description>si-local-file:///var/storage/secattach/20260728/26821738.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+28/26821738.html</guid>
   <pubDate>Tue, 28 Jul 2026 06:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 28</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+28/26821738.html</link>
   <description>si-local-file:///var/storage/secattach/20260728/26821738.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+28/26821738.html</guid>
   <pubDate>Tue, 28 Jul 2026 06:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 27</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+27/26818917.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26818917.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+27/26818917.html</guid>
   <pubDate>Mon, 27 Jul 2026 14:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 27</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+27/26818917.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26818917.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+27/26818917.html</guid>
   <pubDate>Mon, 27 Jul 2026 14:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 27</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+27/26818917.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26818917.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+27/26818917.html</guid>
   <pubDate>Mon, 27 Jul 2026 14:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+23/26807646.html</link>
   <description>si-local-file:///var/storage/secattach/20260723/26807646.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+23/26807646.html</guid>
   <pubDate>Thu, 23 Jul 2026 15:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+23/26807646.html</link>
   <description>si-local-file:///var/storage/secattach/20260723/26807646.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+23/26807646.html</guid>
   <pubDate>Thu, 23 Jul 2026 15:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+23/26807646.html</link>
   <description>si-local-file:///var/storage/secattach/20260723/26807646.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+23/26807646.html</guid>
   <pubDate>Thu, 23 Jul 2026 15:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>CLINUVEL implements strategic reorganisation to refocus on U.S. markets</title>
   <link>http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</link>
   <description>
&lt;p&gt;MELBOURNE, Australia and  NEW YORK, July  23, 2026  (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.&lt;/p&gt;    &lt;p&gt;&amp;quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&amp;apos;s profile is seen as distinct from many</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html</guid>
   <pubDate>Thu, 23 Jul 2026 00:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UR9</category>
   	  </item>
  <item>
   <title>Form  6-K        Clinuvel Pharmaceuticals  For: Jul 21</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+21/26797603.html</link>
   <description>si-local-file:///var/storage/secattach/20260722/26797603.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Clinuvel+Pharmaceuticals++For%3A+Jul+21/26797603.html</guid>
   <pubDate>Wed, 22 Jul 2026 06:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUVL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
 </channel>
</rss>
